Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Nuclear Radiation Therapeutic Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4531937
    • |
  • 23 May, 2023
    • |
  • Global
    • |
  • 106 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Nuclear Radiation Therapeutic Drugs

market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Nuclear Radiation Therapeutic Drugs consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report is a detailed and comprehensive analysis for global Nuclear Radiation Therapeutic Drugs

market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nuclear Radiation Therapeutic Drugs

market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Nuclear Radiation Therapeutic Drugs

market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Nuclear Radiation Therapeutic Drugs

market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Nuclear Radiation Therapeutic Drugs

market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Radiation Therapeutic Drugs

To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nuclear Radiation Therapeutic Drugs

market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global and GE Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Nuclear Radiation Therapeutic Drugs

market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Diagnostic
Therapeutic
Market segment by Application
Oncology
Thyroid
Cardiology
Others
Major players covered
Nihon Medi-Physics Co.,Ltd.
Curium Pharma
Cardinal Health
Bayer Global
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Advanced Molecular-imaging Solution
Ciaeriar
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Radiation Therapeutic Drugs

product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Radiation Therapeutic Drugs

, with price, sales, revenue and global market share of Nuclear Radiation Therapeutic Drugs

from 2018 to 2023.
Chapter 3, the Nuclear Radiation Therapeutic Drugs

competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Radiation Therapeutic Drugs

breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nuclear Radiation Therapeutic Drugs

market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Radiation Therapeutic Drugs

.
Chapter 14 and 15, to describe Nuclear Radiation Therapeutic Drugs

sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Nuclear Radiation Therapeutic Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nuclear Radiation Therapeutic Drugs

Consumption Value by Type: 2018 Versus 2022 Versus 2029

  • 1.3.2 Diagnostic
  • 1.3.3 Therapeutic
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nuclear Radiation Therapeutic Drugs

    • Consumption Value by Application: 2018 Versus 2022 Versus 2029

    • 1.4.2 Oncology
    • 1.4.3 Thyroid
    • 1.4.4 Cardiology
    • 1.4.5 Others
  • 1.5 Global Nuclear Radiation Therapeutic Drugs

    • Market Size & Forecast

    • 1.5.1 Global Nuclear Radiation Therapeutic Drugs

    Consumption Value (2018 & 2022 & 2029)

    • 1.5.2 Global Nuclear Radiation Therapeutic Drugs

    Sales Quantity (2018-2029)

    • 1.5.3 Global Nuclear Radiation Therapeutic Drugs

    Average Price (2018-2029)

      2 Manufacturers Profiles

      • 2.1 Nihon Medi-Physics Co.,Ltd.
        • 2.1.1 Nihon Medi-Physics Co.,Ltd. Details
        • 2.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
        • 2.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs

      Product and Services

      • 2.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
    • 2.2 Curium Pharma
      • 2.2.1 Curium Pharma Details
      • 2.2.2 Curium Pharma Major Business
      • 2.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.2.4 Curium Pharma Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.2.5 Curium Pharma Recent Developments/Updates
    • 2.3 Cardinal Health
      • 2.3.1 Cardinal Health Details
      • 2.3.2 Cardinal Health Major Business
      • 2.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.3.4 Cardinal Health Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.3.5 Cardinal Health Recent Developments/Updates
    • 2.4 Bayer Global
      • 2.4.1 Bayer Global Details
      • 2.4.2 Bayer Global Major Business
      • 2.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.4.4 Bayer Global Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.4.5 Bayer Global Recent Developments/Updates
    • 2.5 GE Healthcare
      • 2.5.1 GE Healthcare Details
      • 2.5.2 GE Healthcare Major Business
      • 2.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.5.4 GE Healthcare Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.5.5 GE Healthcare Recent Developments/Updates
    • 2.6 Mallinckrodt Pharmaceuticals
      • 2.6.1 Mallinckrodt Pharmaceuticals Details
      • 2.6.2 Mallinckrodt Pharmaceuticals Major Business
      • 2.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
    • 2.7 Bracco Group
      • 2.7.1 Bracco Group Details
      • 2.7.2 Bracco Group Major Business
      • 2.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.7.4 Bracco Group Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.7.5 Bracco Group Recent Developments/Updates
    • 2.8 Advanced Molecular-imaging Solution
      • 2.8.1 Advanced Molecular-imaging Solution Details
      • 2.8.2 Advanced Molecular-imaging Solution Major Business
      • 2.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.8.4 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
    • 2.9 Ciaeriar
      • 2.9.1 Ciaeriar Details
      • 2.9.2 Ciaeriar Major Business
      • 2.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.9.4 Ciaeriar Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.9.5 Ciaeriar Recent Developments/Updates
    • 2.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
      • 2.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
      • 2.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
      • 2.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs

      • Product and Services

      • 2.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs

      Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

      • 2.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates

      3 Competitive Environment: Nuclear Radiation Therapeutic Drugs

        by Manufacturer

        • 3.1 Global Nuclear Radiation Therapeutic Drugs

        Sales Quantity by Manufacturer (2018-2023)

        • 3.2 Global Nuclear Radiation Therapeutic Drugs

        Revenue by Manufacturer (2018-2023)

        • 3.3 Global Nuclear Radiation Therapeutic Drugs

        Average Price by Manufacturer (2018-2023)

        • 3.4 Market Share Analysis (2022)
          • 3.4.1 Producer Shipments of Nuclear Radiation Therapeutic Drugs

        by Manufacturer Revenue ($MM) and Market Share (%): 2022

        • 3.4.2 Top 3 Nuclear Radiation Therapeutic Drugs

        Manufacturer Market Share in 2022

        • 3.4.2 Top 6 Nuclear Radiation Therapeutic Drugs

        Manufacturer Market Share in 2022

        • 3.5 Nuclear Radiation Therapeutic Drugs

        Market: Overall Company Footprint Analysis

        • 3.5.1 Nuclear Radiation Therapeutic Drugs

        Market: Region Footprint

        • 3.5.2 Nuclear Radiation Therapeutic Drugs

        Market: Company Product Type Footprint

        • 3.5.3 Nuclear Radiation Therapeutic Drugs

        Market: Company Product Application Footprint

        • 3.6 New Market Entrants and Barriers to Market Entry
        • 3.7 Mergers, Acquisition, Agreements, and Collaborations

        4 Consumption Analysis by Region

        • 4.1 Global Nuclear Radiation Therapeutic Drugs

        Market Size by Region

        • 4.1.1 Global Nuclear Radiation Therapeutic Drugs

        Sales Quantity by Region (2018-2029)

        • 4.1.2 Global Nuclear Radiation Therapeutic Drugs

        Consumption Value by Region (2018-2029)

        • 4.1.3 Global Nuclear Radiation Therapeutic Drugs

        Average Price by Region (2018-2029)

        • 4.2 North America Nuclear Radiation Therapeutic Drugs

        Consumption Value (2018-2029)

        • 4.3 Europe Nuclear Radiation Therapeutic Drugs

        Consumption Value (2018-2029)

        • 4.4 Asia-Pacific Nuclear Radiation Therapeutic Drugs

        Consumption Value (2018-2029)

        • 4.5 South America Nuclear Radiation Therapeutic Drugs

        Consumption Value (2018-2029)

        • 4.6 Middle East and Africa Nuclear Radiation Therapeutic Drugs

        Consumption Value (2018-2029)

          5 Market Segment by Type

          • 5.1 Global Nuclear Radiation Therapeutic Drugs

          Sales Quantity by Type (2018-2029)

          • 5.2 Global Nuclear Radiation Therapeutic Drugs

          Consumption Value by Type (2018-2029)

          • 5.3 Global Nuclear Radiation Therapeutic Drugs

          Average Price by Type (2018-2029)

            6 Market Segment by Application

            • 6.1 Global Nuclear Radiation Therapeutic Drugs

            Sales Quantity by Application (2018-2029)

            • 6.2 Global Nuclear Radiation Therapeutic Drugs

            Consumption Value by Application (2018-2029)

            • 6.3 Global Nuclear Radiation Therapeutic Drugs

            Average Price by Application (2018-2029)

              7 North America

              • 7.1 North America Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Type (2018-2029)

              • 7.2 North America Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Application (2018-2029)

              • 7.3 North America Nuclear Radiation Therapeutic Drugs

              Market Size by Country

              • 7.3.1 North America Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Country (2018-2029)

              • 7.3.2 North America Nuclear Radiation Therapeutic Drugs

              Consumption Value by Country (2018-2029)

              • 7.3.3 United States Market Size and Forecast (2018-2029)
              • 7.3.4 Canada Market Size and Forecast (2018-2029)
              • 7.3.5 Mexico Market Size and Forecast (2018-2029)

              8 Europe

              • 8.1 Europe Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Type (2018-2029)

              • 8.2 Europe Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Application (2018-2029)

              • 8.3 Europe Nuclear Radiation Therapeutic Drugs

              Market Size by Country

              • 8.3.1 Europe Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Country (2018-2029)

              • 8.3.2 Europe Nuclear Radiation Therapeutic Drugs

              Consumption Value by Country (2018-2029)

              • 8.3.3 Germany Market Size and Forecast (2018-2029)
              • 8.3.4 France Market Size and Forecast (2018-2029)
              • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
              • 8.3.6 Russia Market Size and Forecast (2018-2029)
              • 8.3.7 Italy Market Size and Forecast (2018-2029)

              9 Asia-Pacific

              • 9.1 Asia-Pacific Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Type (2018-2029)

              • 9.2 Asia-Pacific Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Application (2018-2029)

              • 9.3 Asia-Pacific Nuclear Radiation Therapeutic Drugs

              Market Size by Region

              • 9.3.1 Asia-Pacific Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Region (2018-2029)

              • 9.3.2 Asia-Pacific Nuclear Radiation Therapeutic Drugs

              Consumption Value by Region (2018-2029)

              • 9.3.3 China Market Size and Forecast (2018-2029)
              • 9.3.4 Japan Market Size and Forecast (2018-2029)
              • 9.3.5 Korea Market Size and Forecast (2018-2029)
              • 9.3.6 India Market Size and Forecast (2018-2029)
              • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
              • 9.3.8 Australia Market Size and Forecast (2018-2029)

              10 South America

              • 10.1 South America Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Type (2018-2029)

              • 10.2 South America Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Application (2018-2029)

              • 10.3 South America Nuclear Radiation Therapeutic Drugs

              Market Size by Country

              • 10.3.1 South America Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Country (2018-2029)

              • 10.3.2 South America Nuclear Radiation Therapeutic Drugs

              Consumption Value by Country (2018-2029)

              • 10.3.3 Brazil Market Size and Forecast (2018-2029)
              • 10.3.4 Argentina Market Size and Forecast (2018-2029)

              11 Middle East & Africa

              • 11.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Type (2018-2029)

              • 11.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Application (2018-2029)

              • 11.3 Middle East & Africa Nuclear Radiation Therapeutic Drugs

              Market Size by Country

              • 11.3.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs

              Sales Quantity by Country (2018-2029)

              • 11.3.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs

              Consumption Value by Country (2018-2029)

              • 11.3.3 Turkey Market Size and Forecast (2018-2029)
              • 11.3.4 Egypt Market Size and Forecast (2018-2029)
              • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
              • 11.3.6 South Africa Market Size and Forecast (2018-2029)

              12 Market Dynamics

              • 12.1 Nuclear Radiation Therapeutic Drugs

              Market Drivers

              • 12.2 Nuclear Radiation Therapeutic Drugs

              Market Restraints

              • 12.3 Nuclear Radiation Therapeutic Drugs

              Trends Analysis

              • 12.4 Porters Five Forces Analysis
                • 12.4.1 Threat of New Entrants
                • 12.4.2 Bargaining Power of Suppliers
                • 12.4.3 Bargaining Power of Buyers
                • 12.4.4 Threat of Substitutes
                • 12.4.5 Competitive Rivalry
              • 12.5 Influence of COVID-19 and Russia-Ukraine War
                • 12.5.1 Influence of COVID-19
                • 12.5.2 Influence of Russia-Ukraine War

              13 Raw Material and Industry Chain

              • 13.1 Raw Material of Nuclear Radiation Therapeutic Drugs

              and Key Manufacturers

              • 13.2 Manufacturing Costs Percentage of Nuclear Radiation Therapeutic Drugs
              • 13.3 Nuclear Radiation Therapeutic Drugs

              Production Process

              • 13.4 Nuclear Radiation Therapeutic Drugs

              Industrial Chain

                14 Shipments by Distribution Channel

                • 14.1 Sales Channel
                  • 14.1.1 Direct to End-User
                  • 14.1.2 Distributors
                • 14.2 Nuclear Radiation Therapeutic Drugs

                Typical Distributors

                • 14.3 Nuclear Radiation Therapeutic Drugs

                Typical Customers

                  15 Research Findings and Conclusion

                    16 Appendix

                    • 16.1 Methodology
                    • 16.2 Research Process and Data Source

                    Summary:
                    Get latest Market Research Reports on Nuclear Radiation Therapeutic Drugs . Industry analysis & Market Report on Nuclear Radiation Therapeutic Drugs is a syndicated market report, published as Global Nuclear Radiation Therapeutic Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Nuclear Radiation Therapeutic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                    Last updated on

                    REPORT YOU MIGHT BE INTERESTED

                    Purchase this Report

                    		$3,480.00
                    		$5,220.00
                    		$6,960.00
                    		2,780.52
                    		4,170.78
                    		5,561.04
                    		3,246.84
                    		4,870.26
                    		6,493.68
                    		541,314.00
                    		811,971.00
                    		1,082,628.00
                    		289,988.40
                    		434,982.60
                    		579,976.80
                    Credit card Logo
                    Sample Question Discount Download PDF

                    Related Reports

                    Reason to Buy

                    • Trusted By Leaders

                      Top executives from leading companies purchase research reports from us. 

                    • Shop With Confidence

                      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

                    • Customer Centric

                      Need assistance related to your research requirements? We are just a phone call or an email away.

                    • Personalized Solutions

                      Our experienced research specialists are here to help you locate the right reports for your need.

                    • Secure Checkout

                      Shop without being worried about safety & security of your transactions.
                      •

                    Request for Sample of this report

                    Reports and Markets

                    mcafree

                    Contact Us

                    +1-352-353-0818 (US)

                    info@reportsandmarkets.com

                    Support

                    EMAIL US

                    Newsletter

                    KEEP UP TO DATE ON ALL THE LATEST REPORTS


                    maxmind_logo